Europe Medical Biomimetics Market Size, Share & Industry Trends Analysis Report By Disease Type, By Application (Wound Healing, Tissue Engineering, Drug Delivery and Others), By Country and Growth Forecast, 2023-2029

The Europe Medical Biomimetics Market should witness market growth of 6.4% CAGR during the forecast period (2023-2029).

The growth of the medical biomimetics market can be attributed to the increasing prevalence of heart and dental diseases. As medical biomimetics can be used to reconstruct broken bones, their usage with the increasing number of road accidents is expected to increase. Additionally, dental biomimetics is utilized in dental bone graft procedures to enhance the density and volume of the jaw in regions where bone loss has taken place.

Dental biomimetic is a dental procedure utilized for tooth replacement and jaw reconstruction in preparation for denture placement. The increasing incidence of dental conditions like dental caries and periodontal diseases, such as gingivitis and periodontitis, drives the need for medical biomimetics.

Central and Eastern Europe has higher death rates from ischemic heart disease (IHD) and stroke than Northern, Southern, and Western Europe. Around 49 million people in the EU and 85 million in Europe are estimated to have had CVD in 2015. Of all the behavioral risk factors, diet had the greatest impact on the likelihood of CVD mortality and CVD DALYs at the population level in Europe. The medical risk factor with the greatest effect is high systolic blood pressure, also known as high blood pressure (BP). The robust prevalence of CVD and the strong presence of a technologically advance healthcare system will raise the adoption of medical biomimetics for their treatment, thus propelling the market growth in the region.

The Germany market dominated the Europe Medical Biomimetics Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $3,692.1 Million by 2029. The UK market is anticipated to grow at a CAGR of 5.6% during (2023-2029). Additionally, The France market would exhibit a CAGR of 7.2% during (2023-2029).

Based on Disease Type, the market is segmented into Dental, Orthopedic, Ophthalmology, Cardiovascular and Others. Based on Application, the market is segmented into Wound Healing, Tissue Engineering, Drug Delivery and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Zimmer Biomet Holdings, Inc., BioHorizons, Inc. (Henry Schein, Inc.), SynTouch Inc., CorNeat Vision Ltd., Osteopore International Pte Ltd, Curasan, Inc., Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.), Swedish Biomimetics 3000 ApS, Keystone Dental Group and Blatchford Limited.

Scope of the Study

By Disease Type

• Dental
• Orthopedic
• Ophthalmology
• Cardiovascular
• Others

By Application

• Wound Healing
• Tissue Engineering
• Drug Delivery
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Zimmer Biomet Holdings, Inc.
• BioHorizons, Inc. (Henry Schein, Inc.)
• SynTouch Inc.
• CorNeat Vision Ltd.
• Osteopore International Pte Ltd
• Curasan, Inc.
• Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.)
• Swedish Biomimetics 3000 ApS
• Keystone Dental Group
• Blatchford Limited

Unique Offerings

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free